Tay Therapeutics
Pre-clinicalWe turn discovery into action, advancing differentiated small molecule medicines through in-house expertise and strategic partnerships. Our therapies aim to address serious conditions where patients are underserved by existing treatments.
Founded
2021
Focus
Small Molecules
About
We turn discovery into action, advancing differentiated small molecule medicines through in-house expertise and strategic partnerships. Our therapies aim to address serious conditions where patients are underserved by existing treatments.
Funding History
1Total raised: $1.8M
Seed$1.8MUndisclosedFeb 15, 2022
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile